✦ LIBER ✦

Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation

✍ Scribed by Guillermo Gervasini; Montserrat Garcia; Rosa María Macias; Juan Jose Cubero; Francisco Caravaca; Julio Benitez

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CYP3A5 and ABCB1 polymorphisms in donor

✍ Glowacki, F.; Lionet, A.; Buob, D.; Labalette, M.; Allorge, D.; Provot, F.; Hazz 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 189 KB

Focus on mTOR inhibitors and tacrolimus

✍ Shihab, Fuad; Christians, Uwe; Smith, Lonnie; Wellen, Jason R.; Kaplan, Bruce 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 926 KB

Impact of CYP3A5 and MDR1(ABCB1) C3435T

✍ H. Tada; N. Tsuchiya; S. Satoh; H. Kagaya; Z. Li; K. Sato; M. Miura; T. Suzuki; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 60 KB

EFFECTS OF GENETIC POLYMORPHISMS OF CYP3

✍ Yong-Fang Hu; Wen Qiu; Zhao-Qian Liu; Li-Jun Zhu; Zhong-Qi Liu; Jiang-Hua Tu; Da 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

The Effect of MDR1 (ABCB1) Polymorphism

✍ S.H. Akbas; T. Bilgen; I. Keser; M. Tuncer; L. Yucetin; O. Tosun; M. Gultekin; G 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Impact of CYP3A5 genetic polymorphism on

✍ Yoshiharu Suzuki; Masato Homma; Kosuke Doki; Fumio Itagaki; Yukinao Kohda 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB